Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Theranostics Market, and What Factors Will Drive It?

With rapid expansion in recent years, the theranostics market is projected to escalate from a size of $111.1 billion in 2024 to $122.98 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. The noticeable growth during the historical period is influenced by the progress in molecular imaging, transition towards value-based healthcare, and its integration into oncology.

The market size for theranostics is predicted to experience a swift surge in the ensuing years. It is anticipated to escalate to a staggering $184.94 billion by the year 2029, with a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the projection span consist of enhancements in precision medicine initiatives, the extension of applications beyond the realm of oncology, an aging population with chronic diseases, developments in biomarker discovery, and financial support from the government. Trending aspects during this period include regulatory backing, the emergence of companion diagnostics, an amplified emphasis on cancer theranostics, increased patient involvement and awareness, and technological synergy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTheranostics Market?

The increasing incidence of cancer is anticipated to drive the growth of the theranostics market. Cancer is characterized by unregulated cell proliferation that affects various organs, leading to considerable morbidity and mortality globally. Theranostics, a combination of therapy and diagnostics, presents significant potential in managing cancer and other chronic diseases. This approach facilitates individualized and targeted therapies by merging diagnostic and therapeutic capabilities, thus sparking innovation opportunities in the healthcare sector. Consequently, an increase in cancer patients will contribute to the theranostics market expansion. For example, the National Cancer Institute (NCI), a US government agency under the National Institutes of Health (NIH) tasked with cancer research, prevention, and treatment, stated in January 2022 that about 5.4% of the US population, equating to 18.1 million people, are cancer survivors. Furthermore, there were 623,405 individuals living with metastatic cancer of the breast, prostate, lung, colorectal, or bladder, or metastatic melanoma in 2022. This figure is forecasted to climb to 693,452 by 2025. As a result, the escalating incidence of cancer is fueling the theranostics market.

Which Segments in the Theranostics Offer the Most Growth?

The theranosticsmarket covered in this report is segmented –

1) By Disease Type: Neurological Disorders; Cardiovascular Diseases; Immunological Disorders; Oncology Diseases; Other Diseases

2) By Technology: Polymerase Chain Reaction; Immunohistochemistry; In-Situ Hybridization; Sequencing; Other Technologies

3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users

Subsegments:

1) By Neurological Disorders: Alzheimer’s Disease; Parkinson’s Disease; Multiple Sclerosis; Epilepsy; Other Neurological Disorders

2) By Cardiovascular Diseases: Coronary Artery Disease; Heart Failure; Atrial Fibrillation; Hypertension; Other Cardiovascular Diseases

3) By Immunological Disorders: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Inflammatory Bowel Disease; Psoriasis; Other Immunological Disorders

4) By Oncology Diseases: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Other Oncology Diseases

5) By Other Diseases: Infectious Diseases; Metabolic Disorders; Genetic Disorders; Other Diseases

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10823&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTheranostics Market?# Market?

North America was the largest region in the global theranostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Theranostics Industry?

Leaders in the theranostics market, such as BAMF Health, are concentrating on the development of cutting-edge solutions like clinical trials in theranostics. The goal is to improve individualized medicine and patient results by amalgamating diagnostics and therapeutics. Theranostics clinical trials are research initiatives that study the concurrent application of diagnostic evaluations and targeted treatments to customize therapeutic plans for each patient. The objective is to ascertain the efficacy of specific therapies on the strength of individual patient’s biomarkers, thus, advancing personalized medicine. As an illustration, in May 2024, BAMF Health, a US-based oncology treatment provider, initiated the COMBAT Trial, formally known as “A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617” (NCT05633160). The BAMF RapAct program facilitated the prompt launch of the trial in a mere seven weeks, with a primary emphasis placed on the application of pioneering radiopharmaceuticals aimed at the Gastrin-Releasing Peptide receptor (GRPR), to enhance treatment possibilities for patients with limited available options.

View the full report here:

https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

What Are the Key Elements That Define the Theranostics Market?

Theranostics is a medical field combining therapeutics and diagnostics into a single, integrated approach. It involves developing and applying diagnostic tests that not only detect diseases or conditions but also provide information to guide personalized therapeutic interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10823

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model